{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:23:44Z","timestamp":1755221024528,"version":"3.43.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,7]]},"DOI":"10.7759\/cureus.89589","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T05:53:51Z","timestamp":1754632431000},"source":"Crossref","is-referenced-by-count":0,"title":["A Symptom-Based Algorithm for Rapid Clinical Diagnosis of COVID-19 in Adults With High-Risk Exposure"],"prefix":"10.7759","author":[{"given":"Shinji","family":"Inaba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuntaro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyosei","family":"Sogabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuji","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36614","article-title":"Simple symptom-based prediction of COVID-19: a single-center study of outpatient fever clinic in Japan","volume":"15","author":"Inaba S","year":"2023","unstructured":"Inaba S, Nakao Y, Ikeda S, et al.. Simple symptom-based prediction of COVID-19: a single-center study of outpatient fever clinic in Japan. Cureus. 2023, 15:e36614. 10.7759\/cureus.36614","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.68749","article-title":"Diagnosis of COVID-19: is fever the best indicator of COVID-19 in vaccinated SARS-CoV-2-positive adults?","volume":"16","author":"Inaba S","year":"2024","unstructured":"Inaba S, Ikeda S, Fujiwara Y, et al.. Diagnosis of COVID-19: is fever the best indicator of COVID-19 in vaccinated SARS-CoV-2-positive adults?. Cureus. 2024, 16:e68749. 10.7759\/cureus.68749","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.1c01451","article-title":"Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance","volume":"62","author":"Chen J","year":"2022","unstructured":"Chen J, Wang R, Gilby NB, Wei GW. Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance. J Chem Inf Model. 2022, 62:412-22. 10.1021\/acs.jcim.1c01451","journal-title":"J Chem Inf Model"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00461-z","article-title":"Considerations for diagnostic COVID-19 tests","volume":"19","author":"Vandenberg O","year":"2021","unstructured":"Vandenberg O, Martiny D, Rochas O, van Belkum A, Kozlakidis Z. Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol. 2021, 19:171-83. 10.1038\/s41579-020-00461-z","journal-title":"Nat Rev Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242958","article-title":"False-negative results of initial RT-PCR assays for COVID-19: a systematic review","volume":"15","author":"Arevalo-Rodriguez I","year":"2020","unstructured":"Arevalo-Rodriguez I, Buitrago-Garcia D, Simancas-Racines D, et al.. False-negative results of initial RT-PCR assays for COVID-19: a systematic review. PLoS One. 2020, 15:e0242958. 10.1371\/journal.pone.0242958","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013705.pub2","article-title":"Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection","volume":"3","author":"Dinnes J","year":"2021","unstructured":"Dinnes J, Deeks JJ, Berhane S, et al.. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2021, 3:CD013705. 10.1002\/14651858.CD013705.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","unstructured":"Ministry of Health, Labour and Welfare, Japan. Handling of COVID-19 \u201cpresumed positive\u201d cases based on clinical judgment without testing. (2022). Accessed. June 22, 2025: https:\/\/www.mhlw.go.jp\/stf\/covid-19\/kenkou-iryousoudan.html."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda Y","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013, 48:452-8. 10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1808","article-title":"Interpreting a covid-19 test result","volume":"369","author":"Watson J","year":"2020","unstructured":"Watson J, Whiting PF, Brush JE. Interpreting a covid-19 test result. BMJ. 2020, 369:m1808. 10.1136\/bmj.m1808","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1495","article-title":"Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure","volume":"173","author":"Kucirka LM","year":"2020","unstructured":"Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med. 2020, 173:262-7. 10.7326\/M20-1495","journal-title":"Ann Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMx210021","article-title":"Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines","volume":"390","author":"Thompson MG","year":"2024","unstructured":"Thompson MG, Burgess JL, Naleway AL, et al.. Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines. N Engl J Med. 2024, 390:772. 10.1056\/NEJMx210021","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan WJ","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020, 382:1708-20. 10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.03.005","article-title":"Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management","volume":"41","author":"Ikewaki N","year":"2023","unstructured":"Ikewaki N, Kurosawa G, Levy GA, Preethy S, Abraham SJ. Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management. Vaccine. 2023, 41:2427-9. 10.1016\/j.vaccine.2023.03.005","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa518","article-title":"COVID-19 vaccines: should we fear ADE?","volume":"222","author":"Halstead SB","year":"2020","unstructured":"Halstead SB, Katzelnick L. COVID-19 vaccines: should we fear ADE?. J Infect Dis. 2020, 222:1946-50. 10.1093\/infdis\/jiaa518","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11050991","article-title":"IgG4 antibodies induced by repeated vaccination may generate immune tolerance to the SARS-CoV-2 spike protein","volume":"11","author":"Uversky VN","year":"2023","unstructured":"Uversky VN, Redwan EM, Makis W, Rubio-Casillas A. IgG4 antibodies induced by repeated vaccination may generate immune tolerance to the SARS-CoV-2 spike protein. Vaccines (Basel). 2023, 11:1. 10.3390\/vaccines11050991","journal-title":"Vaccines (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30287-5","article-title":"Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study","volume":"20","author":"Bi Q","year":"2020","unstructured":"Bi Q, Wu Y, Mei S, et al.. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020, 20:911-9. 10.1016\/S1473-3099(20)30287-5","journal-title":"Lancet Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254990","article-title":"Predictors of COVID-19 in an outpatient fever clinic","volume":"16","author":"Tr\u00fcbner F","year":"2021","unstructured":"Tr\u00fcbner F, Steigert L, Echterdiek F, et al.. Predictors of COVID-19 in an outpatient fever clinic. PLoS One. 2021, 16:e0254990. 10.1371\/journal.pone.0254990","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.9317","article-title":"Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis","volume":"5","author":"Madewell ZJ","year":"2022","unstructured":"Madewell ZJ, Yang Y, Longini IM Jr, Halloran ME, Dean NE. Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis. JAMA Netw Open. 2022, 5:e229317. 10.1001\/jamanetworkopen.2022.9317","journal-title":"JAMA Netw Open"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221083751","article-title":"Comparison of the clinical parameters of patients with COVID-19 and influenza using blood test data: a retrospective cross-sectional survey","volume":"50","author":"Fukui S","year":"2022","unstructured":"Fukui S, Inui A, Saita M, Kobayashi D, Naito T. Comparison of the clinical parameters of patients with COVID-19 and influenza using blood test data: a retrospective cross-sectional survey. J Int Med Res. 2022, 50:3000605221083751. 10.1177\/03000605221083751","journal-title":"J Int Med Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2022.105","article-title":"Comparison of coronavirus disease 2019 (COVID-19) symptoms at diagnosis among healthcare personnel before and after the emergence of the omicron variant","volume":"44","author":"Laracy JC","year":"2023","unstructured":"Laracy JC, Robilotti EV, Yan J, Lucca A, Aslam A, Babady NE, Kamboj M. Comparison of coronavirus disease 2019 (COVID-19) symptoms at diagnosis among healthcare personnel before and after the emergence of the omicron variant. Infect Control Hosp Epidemiol. 2023, 44:821-3. 10.1017\/ice.2022.105","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/391498-a-symptom-based-algorithm-for-rapid-clinical-diagnosis-of-covid-19-in-adults-with-high-risk-exposure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T05:53:53Z","timestamp":1754632433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/391498-a-symptom-based-algorithm-for-rapid-clinical-diagnosis-of-covid-19-in-adults-with-high-risk-exposure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.89589","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,7]]}}}